Reset Therapeutics

Developer of psychedelic therapeutics for mental illness

placeSan Francisco, California, United States calendar_todayFounded 2008 groups26 employees language resettherapeutics.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,221 times.

YearFilings
20131
20141
20152
20162
20172
20182
20192
20201
20211
20231

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Bank & private debt150%
Coming soon